Scarica l'app Stockscreener
2.26
5.61%
0.12
Precedente Chiudi:
$2.14
Aprire:
$2.18
Volume 24 ore:
49,740
Relative Volume:
0.64
Capitalizzazione di mercato:
$5.57M
Reddito:
Utile/perdita netta:
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
1 W Prestazione:
+10.78%
1M Prestazione:
+2.73%
6M Prestazione:
-82.51%
1 anno Prestazione:
-92.15%
Intervallo 1D:
$2.1063
$2.4195
Intervallo di 1 settimana:
$1.70
$2.3995
Portata 52W:
$1.628
$30.96
Cellyan Biotechnology Co Ltd Stock (HKPD) Company Profile
Nome
Cellyan Biotechnology Co Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Compare HKPD vs MCK, COR, CAH, HSIC, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HKPD
Cellyan Biotechnology Co Ltd
|
2.26 | 5.57M | 0 | 0 | 0 | 0.00 |
MCK
Mckesson Corp
|
962.10 | 112.17B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
325.95 | 62.20B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
245.84 | 56.93B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
85.10 | 9.48B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.29 | 1.11B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cellyan Biotechnology Co Ltd Borsa (HKPD) Ultime notizie
Cellyan Biotechnology to implement 1-for-20 reverse stock split By Investing.com - Investing.com Nigeria
Cellyan Biotechnology to implement 1-for-20 reverse stock split By Investing.com - Investing.com India
Cellyan Biotechnology to implement 1-for-20 reverse stock split By Investing.com - Investing.com UK
Cellyan Biotechnology Announces a 1-for-20 Reverse Stock Split - Yahoo Finance
Twenty shares are expected to become one as Cellyan seeks to meet Nasdaq's minimum share-price rule. - Stock Titan
HXHX Stock Price, Quote & News - Syfe
Cellyan Biotechnology Shareholders Approve 1-for-20 Consolidation and Charter Overhaul - The Globe and Mail
Cellyan Biotechnology Shareholders Approve 1-for-20 Consolidation and Charter Overhaul - TipRanks
Cellyan Biotechnology (NASDAQ: HKPD) Announces Extraordinary Meeting on September 21, 2026 for Share Consolidation Proposal - Kalkine Media
12 Industrials Stocks Moving In Thursday's Pre-Market Session - benzinga.com
Cellyan Biotechnology Calls September 21 EGM to Approve 1-for-20 Share Consolidation - TipRanks
Microcaps GPRO, FLYE, HKPD, VIVS to Watch Now - marketscreener.com
12 Industrials Stocks Moving In Wednesday's Pre-Market Session - benzinga.com
12 Industrials Stocks Moving In Tuesday's After-Market Session - benzinga.com
Microcaps GPRO, FLYE, HKPD, VIVS to Watch Now - FinancialContent
12 Industrials Stocks Moving In Tuesday's Intraday Session - benzinga.com
JYD Stock Price, Quote & News - Syfe
Click Files up to $100 Million Mixed Shelf - Yahoo Finance
Cellyan Biotechnology (HKPD) Advances 3.61% as Shares Approach Key $0.44 ResistanceMA Cross Alert - vinanet.vn
Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement - Yahoo Finance
SunCar Technology Group Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Compliance Deficiency - Yahoo Finance
Kam Leung Chan Net Worth (2026) - GuruFocus
These stocks have an unusual volume in today's session - ChartMill
Jingyan Wu Net Worth (2026) - GuruFocus
Shu Liu Net Worth (2026) - GuruFocus
Chenyu Andy Liang Net Worth (2026) - GuruFocus
Zifeng Wang Net Worth (2026) - GuruFocus
Mike Yao Zhou Net Worth (2026) - GuruFocus
Cellyan Biotechnology granted Nasdaq compliance extension; shares surge - MSN
Cellyan Biotechnology stock sinks 21% after hours: Here's what happened - MSN
Cellyan Biotechnology granted Nasdaq compliance extension; shares surge - MSN
What's going on in today's pre-market session - ChartMill
12 Industrials Stocks Moving In Friday's Pre-Market Session - Benzinga
Cellyan Biotechnology Wins Second Nasdaq Grace Period to Fix Sub-$1 Share Price - TipRanks
Cellyan Biotechnology stock sinks 21% after hours: Here's what happened - MSN
Cellyan Biotechnology Stock Sinks 21% After Hours: Here's What Happened - Benzinga
Cellyan Biotechnology Gets 180-Day Nasdaq Grace Period on Bid-Price Rule - marketscreener.com
Cellyan Biotechnology gets 180-day extension for Nasdaq compliance By Investing.com - Investing.com Nigeria
12 Industrials Stocks Moving In Thursday's After-Market Session - Benzinga
Cellyan Biotechnology granted Nasdaq compliance extension; shares surge - MSN
Thursday's after hours session: top gainers and losers - ChartMill
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period - The Manila Times
Cellyan Biotechnology gets 180-day extension for Nasdaq compliance - Investing.com
Cellyan Biotechnology Receives Nasdaq Extension to Regain Minimum Bid Price Compliance | HKPD Stock News - Quiver Quantitative
Nasdaq grants Cellyan Biotechnology (Nasdaq: HKPD) bid-price extension - Stock Titan
Ohmyhome Ltd Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency - Yahoo Finance
Cellyan Biotechnology Must Reach $1 Bid Price by Jan. 11 - Stock Titan
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period - Yahoo Finance
Cellyan Biotech (HKPD) Holds Steady Near Support After Minor DeclineMA Cross Alert - dars.gov.et
12 Industrials Stocks Moving In Wednesday's Intraday Session - Benzinga
Cellyan Biotechnology Co Ltd Azioni (HKPD) Dati Finanziari
Non sono disponibili dati finanziari per Cellyan Biotechnology Co Ltd (HKPD). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
7.77%
8.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):